Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Massaro

Showing results (391-400 of 422) with videos related to

Pageof 43
Sort By:
The American Journal of Cardiology|April 17, 2018
Observational and Genetic Associations of Resting Heart Rate With Aortic Valve CalciumSeamus P Whelton, Andreas C Mauer, Karol M Pencina, et al.
Clinical Cardiology|August 27, 2016
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With StentingChristopher P Cannon, Savion Gropper, Deepak L Bhatt, et al.
Journal of the American Heart Association|May 18, 2024
Cardiovascular Risk Estimation Is Suboptimal in People With HIVVirginia A Triant, Asya Lyass, Leo B Hurley, et al.
JAMA|March 30, 2016
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary InterventionRobert W Yeh, Eric A Secemsky, Dean J Kereiakes, et al.
The New England Journal of Medicine|April 6, 2011
Percutaneous repair or surgery for mitral regurgitationTed Feldman, Elyse Foster, Donald D Glower, et al.
Circulation|November 17, 2017
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled TrialTed Feldman, Laura Mauri, Rami Kahwash, et al.
Lancet (London, England)|March 3, 2009
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort studyRenate B Schnabel, Lisa M Sullivan, Daniel Levy, et al.
Circulation|November 25, 2016
Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial AngiographyHanna K Gaggin, Yuyin Liu, Asya Lyass, et al.
JAMA|September 1, 2010
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosisDeepak L Bhatt, Kim A Eagle, E Magnus Ohman, et al.
Journal of the American College of Cardiology|March 18, 2017
Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume OverloadMarvin A Konstam, Michael Kiernan, Arthur Chandler, et al.
Pageof 43

Showing results (391-400 of 422) with videos related to

Sort By:
Pageof 43
The American Journal of Cardiology|April 17, 2018
Observational and Genetic Associations of Resting Heart Rate With Aortic Valve CalciumSeamus P Whelton, Andreas C Mauer, Karol M Pencina, et al.
Clinical Cardiology|August 27, 2016
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With StentingChristopher P Cannon, Savion Gropper, Deepak L Bhatt, et al.
Journal of the American Heart Association|May 18, 2024
Cardiovascular Risk Estimation Is Suboptimal in People With HIVVirginia A Triant, Asya Lyass, Leo B Hurley, et al.
JAMA|March 30, 2016
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary InterventionRobert W Yeh, Eric A Secemsky, Dean J Kereiakes, et al.
The New England Journal of Medicine|April 6, 2011
Percutaneous repair or surgery for mitral regurgitationTed Feldman, Elyse Foster, Donald D Glower, et al.
Circulation|November 17, 2017
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled TrialTed Feldman, Laura Mauri, Rami Kahwash, et al.
Lancet (London, England)|March 3, 2009
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort studyRenate B Schnabel, Lisa M Sullivan, Daniel Levy, et al.
Circulation|November 25, 2016
Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial AngiographyHanna K Gaggin, Yuyin Liu, Asya Lyass, et al.
JAMA|September 1, 2010
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosisDeepak L Bhatt, Kim A Eagle, E Magnus Ohman, et al.
Journal of the American College of Cardiology|March 18, 2017
Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume OverloadMarvin A Konstam, Michael Kiernan, Arthur Chandler, et al.
Pageof 43